سعر ابيدرا 100 وحدة دولية/مل 5 خرطوشات 2025

Apidra 100 IU/ml solution for injection in cartridge: rapid-acting human insulin analogue (insulin glulisine 100 units/ml) by Sanofi; box of 5 cartridges.

• Improve glycaemic control in diabetes mellitusPopulation: Adults and pediatric patients (pediatric data in type 1 diabetes from 4 years)DailyMed (U.S. National Library of Medicine)

• Hypoglycaemia, allergic reactions, injection-site reactions, lipodystrophy, pruritus, rash and weight gain.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• During episodes of hypoglycaemia.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity to insulin glulisine or any excipient.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Never share pens, cartridges, needles or syringes between patients (blood-borne pathogen transmission).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Changes in insulin regimen (strength, manufacturer, type, injection site) may cause hyper- or hypoglycaemia; make changes under close supervision with increased glucose monitoring.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Hypoglycaemia is the most common adverse reaction and can be severe or fatal; awareness may be reduced (long-standing diabetes, neuropathy, beta-blockers).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Antidiabetic agents, ACE inhibitors, ARBs, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, pramlintide, salicylates, octreotide, sulfonamide antibioticsMay increase hypoglycaemia risk; dose adjustment and more frequent glucose monitoring may be required.DailyMed (U.S. National Library of Medicine)
• Atypical antipsychotics, corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics, thyroid hormonesMay decrease the glucose-lowering effect; dose adjustment and more frequent glucose monitoring may be required.DailyMed (U.S. National Library of Medicine)

• Pharmacovigilance data have not established an association with major birth defects, miscarriage or adverse maternal/fetal outcomes; poorly controlled diabetes in pregnancy carries maternal and fetal risks.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Human insulin products, including insulin glulisine, are transferred into human milk; no adverse reactions reported in breastfed infants.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Insulin glulisine: Lowers blood glucose by stimulating peripheral glucose uptake by skeletal muscle and fat and inhibiting hepatic glucose production; inhibits lipolysis and proteolysis and enhances protein synthesis (US Apidra label).